These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16264828)

  • 21. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue microarrays: emerging standard for biomarker validation.
    Hassan S; Ferrario C; Mamo A; Basik M
    Curr Opin Biotechnol; 2008 Feb; 19(1):19-25. PubMed ID: 18053705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
    Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
    BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of tissue microarrays in prostate cancer biomarker discovery.
    Datta MW; True LD; Nelson PS; Amin MB
    Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross platform microarray analysis for robust identification of differentially expressed genes.
    Bosotti R; Locatelli G; Healy S; Scacheri E; Sartori L; Mercurio C; Calogero R; Isacchi A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17430572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving cancer diagnostics from bench to bedside.
    Zhang X; Li L; Wei D; Yap Y; Chen F
    Trends Biotechnol; 2007 Apr; 25(4):166-73. PubMed ID: 17316853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
    Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
    Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].
    Jacquemier J; Ginestier C; Charafe-Jauffret E; Bertucci F; Bege T; Geneix J; Birnbaum D
    Ann Pathol; 2003 Dec; 23(6):623-32. PubMed ID: 15094604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential glycan profiling by lectin microarray targeting tissue specimens.
    Kuno A; Matsuda A; Ikehara Y; Narimatsu H; Hirabayashi J
    Methods Enzymol; 2010; 478():165-79. PubMed ID: 20816479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ELISA microarray technology as a high-throughput system for cancer biomarker validation.
    Zangar RC; Daly DS; White AM
    Expert Rev Proteomics; 2006 Feb; 3(1):37-44. PubMed ID: 16445349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent component analysis-based penalized discriminant method for tumor classification using gene expression data.
    Huang DS; Zheng CH
    Bioinformatics; 2006 Aug; 22(15):1855-62. PubMed ID: 16709589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue microarray studies in bladder cancer.
    Hartmann A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarrays--chances and challenges.
    Pilarsky CP; Schmitt AO; Dahl E; Rosenthal A
    Curr Opin Mol Ther; 1999 Dec; 1(6):727-36. PubMed ID: 19629870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA array/microarrays in oncological research with focus on pancreatic cancer.
    Baron A; Moore PS; Scarpa A
    Adv Clin Path; 2001 Oct; 5(4):115-20. PubMed ID: 17582935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue microarray: a new technology for amplification of tissue resources.
    Rimm DL; Camp RL; Charette LA; Costa J; Olsen DA; Reiss M
    Cancer J; 2001; 7(1):24-31. PubMed ID: 11269645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New member of chip family--tissue microarray].
    Deng ZH; Zhou JH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):102-4. PubMed ID: 16137021
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples.
    Dumur CI; Sana S; Ladd AC; Ferreira-Gonzalez A; Wilkinson DS; Powers CN; Garrett CT
    Diagn Mol Pathol; 2008 Dec; 17(4):200-6. PubMed ID: 18382347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedside.
    Roepman P
    Bioanalysis; 2010 Feb; 2(2):249-62. PubMed ID: 21083308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA microarrays--perspective of application for drug effectivity and safety evaluation].
    Roman I
    Postepy Biochem; 2008; 54(1):107-15. PubMed ID: 18610588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.